Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Eoganachton Jan 15, 2020 3:21pm

211 Views

Post# 30557049

RE:RE:Former Theralase Director of Investor Relations Guilty

In early 2016, after asking Stockhouse to remove some of the posts, Roger Dumoulin-White wrote that Michael Borovec was let go because of performance related issues.

Oilminerdeluxe wrote: I wonder what brought on his wrath? I mean, there must have been som bad blood there. Watching the wrong internet sites during working hours perhaps? Interesting read. Thanks for posting it.

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment